Augmedix Osake

Augmedix PEG

Delisted

PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Augmedix (AUGX) 10.8.2026 päivämäärällä on −0,14.

PEG

−0,14

Viimeksi päivitetty:

PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Augmedix on 2026 −0,14 . PEG-suhde (Hinta-tuotto-kasvu-suhde) yhtiöstä Augmedix oli 2025 0,00 . Se laskee % matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Augmedix Osakeanalyysi

Mitä Augmedix tekee? Augmedix Inc. is a San Francisco-based company specializing in the development of technologies and software to assist medical professionals. It was founded in 2012 by Ian Shakil and Pelu Tran to change the way doctors capture and document patient data. The decision to start Augmedix was influenced by the personal experiences of the two founders. While working in the emergency room, Shakil noticed that he was constantly turning his back on his patients to create medical records, which took away from the actual treatment and interrupted visual contact with the patient. Based on his experiences, he saw an opportunity to help doctors focus more on their patients. Pelu Tran, the other founder, also worked in the healthcare industry and wanted to help doctors and nurses have more time for patient care. Augmedix's business model is based on the integration of speech technology and virtual reality. Augmedix has developed specialized software that directs doctors' attention away from data entry and towards treating their patients. Instead of focusing on writing notes, dictation, and clarifying paper notes, doctors can speak directly to a virtual assistant in real-time, who automates their records and embeds them into their medical records. Through this process automation, doctors can spend more time caring for their patients. Augmedix has now specialized in various areas within medical technology. For example, Augmedix offers speech technology platforms that surgical teams can use to access patient information and follow care protocols during surgery without leaving the operating table. There are also wireless mobile headsets that allow doctors to access patient information and create notes during patient treatment without interrupting contact between the doctor and patient. Augmedix also offers a telemedicine telepresence system that allows doctors and patients to communicate with each other via video calls. The system provides a convenient way for both patients and doctors to conduct and receive video consultations without the need for physical presence. Augmedix has become a major player in the digital healthcare industry, especially for doctors and hospitals. The company has already gained many customers in the US healthcare sector, including dozens of leading clinic chains. With its unique business model, Augmedix has taken a pioneering role in introducing new technologies in healthcare. In collaboration with the cloud computing platform Google Cloud, a dedicated medical security cloud platform and application for the healthcare industry are now being developed. Augmedix and Google Cloud now enable doctors to send medical data in real-time to their Augmedix virtual assistant and simultaneously update existing HIPAA-compliant patient records. Overall, Augmedix has become an important company for the introduction of new technologies in healthcare and can be proud to support doctors in their work and optimize healthcare for patients. Augmedix on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Augmedix osakkeesta

Yhtiön Augmedix PEG-suhde (Hinta-tuotto-kasvu-suhde) on −0,14 vuonna 2026.

Eurpoolissa voit löytää PEG-suhde (Hinta-tuotto-kasvu-suhde) Augmedix:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

PEG-suhde korjaa P/E-suhteen odotetulla tuottojen kasvuvauhdilla. PEG alle 1 voi viitata osakkeeseen, joka on aliarvostettu suhteessa sen kasvupotentiaaliin.

PEG = P/E-suhde / Odotettu vuosittainen EPS-kasvuprosentti

Arvioidakseen PEG-suhde (Hinta-tuotto-kasvu-suhde):n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja PEG-suhde (Hinta-tuotto-kasvu-suhde):lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata PEG-suhde (Hinta-tuotto-kasvu-suhde):n Augmedix alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Augmedix

Kaikki tunnusluvut — Augmedix